Functions of γC cytokines in immune homeostasis: Current and potential clinical applications

被引:87
作者
Overwijk, Willem W. [2 ]
Schluns, Kimberly S. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
关键词
Common gamma chain; Lymphocyte homeostasis; Cytokine therapy; Lymphopenia-induced proliferation; Adoptive cell therapy; Tumor-infiltrating lymphocytes; Regulatory T cells; Immune reconstitution; Human immunodeficiency virus; CD8(+) T-CELLS; VIVO ANTITUMOR-ACTIVITY; IN-VIVO; METASTATIC MELANOMA; NATURAL-KILLER; BONE-MARROW; INTERLEUKIN-2; THERAPY; SELECTIVE STIMULATION; DOSE INTERLEUKIN-2; CANCER REGRESSION;
D O I
10.1016/j.clim.2009.03.512
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Cytokines that signal through receptor complexes containing the common gamma (gamma C) chain receptor subunit are central regulators of lymphocyte homeostasis. In this review, we discuss the four major gamma C cytokines that have proven activity in or potential for immunotherapy: IL-2, IL-7, IL-15 and IL-21. Their shared and unique activities on specific lymphocyte populations suggest therapeutic applications such as enhancing lymphocyte reconstitution, expanding tumor and pathogen-specific lymphocytes, and optimizing vaccines. Because the responsiveness of individual lymphocyte subsets varies under different situations such as lymphopenia and active immune responses, understanding the dynamics of gamma C-containing receptor expression is important in deciding how to achieve the most desired effect. Current understanding of the biology of gamma C cytokines suggests several clinical, applications, including their direct administration or use in generation of lymphocytes for adoptive transfer, increasing their endogenous production, and potentiating their activity by complex formation with specific antibodies or their specific receptor-alpha subunits. Overall, gamma C cytokines have great potential, through their targeted use atone or in combination, to be an integral part of clinical interventions with enhanced efficacy and decreased toxicity. Published by Elsevier Inc.
引用
收藏
页码:153 / 165
页数:13
相关论文
共 93 条
[1]
IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients [J].
Ahmadzadeh, M ;
Rosenberg, ST .
BLOOD, 2006, 107 (06) :2409-2414
[2]
CD4+ T-regulatory cells:: toward therapy for human diseases [J].
Allan, Sarah E. ;
Broady, Raewyn ;
Gregori, Silvia ;
Himmel, Megan E. ;
Locke, Natasha ;
Roncarolo, Maria Grazia ;
Bacchetta, Rosa ;
Levings, Megan K. .
IMMUNOLOGICAL REVIEWS, 2008, 223 :391-421
[3]
CHROMOSOMAL ASSIGNMENT AND GENOMIC STRUCTURE OF IL15 [J].
ANDERSON, DM ;
JOHNSON, L ;
GLACCUM, MB ;
COPELAND, NG ;
GILBERT, DJ ;
JENKINS, NA ;
VALENTINE, V ;
KIRSTEIN, MN ;
SHAPIRO, DN ;
MORRIS, SW ;
GRABSTEIN, K ;
COSMAN, D .
GENOMICS, 1995, 25 (03) :701-706
[4]
ANDERSON DM, 1995, J BIOL CHEM, V270, P29862
[5]
Bamford RN, 1998, J IMMUNOL, V160, P4418
[6]
Cell-surface IL-7 receptor expression facilitates the purification of FOXP3+ regulatory T cells [J].
Banham, Alison H. .
TRENDS IN IMMUNOLOGY, 2006, 27 (12) :541-544
[7]
Adoptive immunotherapy for posttransplantation viral infections [J].
Bollard, CM ;
Kuehnle, I ;
Leen, A ;
Rooney, CM ;
Heslop, HE .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (03) :143-155
[8]
Selective stimulation of T cell subsets with antibody-cytokine immune complexes [J].
Boyman, O ;
Kovar, M ;
Rubinstein, MP ;
Surh, CD ;
Sprent, J .
SCIENCE, 2006, 311 (5769) :1924-1927
[9]
IL-7/Anti-IL-7 mAb complexes restore T cell development and induce homeostatic T cell expansion without lymphopenia [J].
Boyman, Onur ;
Ramsey, Chris ;
Kim, David M. ;
Sprent, Jonathan ;
Surh, Charles D. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (11) :7265-7275
[10]
Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease [J].
Boyman, Onur ;
Surh, Charles D. ;
Sprent, Jonathan .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (12) :1323-1331